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ABSTRACT Thyrotropin is the primary hormone that,
via one heptahelical receptor, regulates thyroid cell functions
such as secretion, specific gene expression, and growth. In
human thyroid, thyrotropin receptor activation leads to stim-
ulation of the adenylyl cyclase and phospholipase C cascades.
However, the G proteins involved in thyrotropin receptor
action have been only partially defined. In membranes of
human thyroid gland, we immunologically identified a sub-
units of the G proteins Gs short, Gs long, Gil, GM2, Gu, Go (Go2 and
another form of G., presumably Go,), Gq, Gli, G12, and G13.
Activation of the thyrotropin (TSH) receptor by bovine TSH
led to increased incorporation of the photoreactive GTP
analogue [a-32P]GTP azidoanilide into immunoprecipitated
a subunits of all G proteins detected in thyroid membranes.
This effect was receptor-dependent and not due to direct G
protein stimulation because it was mimicked byTSH receptor-
stimulating antibodies of patients suffering from Grave dis-
ease and was abolished by a receptor-blocking antiserum from
a patient with autoimmune hypothyroidism. The TSH-induced
activation of individual G proteins occurred with EC50 values
of 5-50 milliunits/ml, indicating that the activated TSH
receptor coupled with similar potency to different G proteins.
When human thyroid slices were pretreated with pertussis
toxin, the TSH receptor-mediated accumulation of cAMP
increased by -35% with TSH at 1 milliunits/ml, indicating
that the TSH receptor coupled to Gs and GI. Taken together,
these findings show that, at least in human thyroid mem-
branes, in which the protein is expressed at its physiological
levels, the TSH receptor resembles a naturally occurring
example of a general G protein-activating receptor.
A large group of receptors regulates cellular functions by
coupling to and activating heterotrimeric GTP-binding pro-
teins (G proteins) (1-3). G proteins are defined by their a
subunits, which exhibit a considerable structural and func-
tional diversity and can be assigned to four families, G,, Gi, Gq,
and G12, according to sequence homologies of the a subunits
(2). As many receptors have been shown to interact with
several G proteins to elicit their cellular effects (4, 5), it is
assumed that accurate signal transduction requires activated
receptors to interact specifically with a certain pattern of G
proteins. Indeed, reconstitution, cotransfection, and biochem-
ical in situ experiments have shown that there is a certain
degree of specificity in the receptor-G protein interaction.
With these different methodological approaches, coupling of
receptors to G proteins of G1 and Go subtypes (6, 7), to Gi and
Gq family members (8), to G1 and Gs (9), to Gi, Gq, and G12
family members (10), or to G1, Gq, and G, (11, 12) has been
demonstrated.
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Thyrotropin (TSH), the main physiological regulator of the
thyroid gland, exerts its cellular effects by binding to a mem-
branous receptor that belongs to the group of G protein-
coupled receptors (13). By immunoprecipitating receptor-
dependently photolabeled G protein a subunits, we recently
showed that the human TSH receptor can interact with G, and
Gq/11 (14), leading to the activation of adenylyl cyclase and
phospholipase C, respectively (15). Thus we extended our
examinations and made the unexpected observation that the
human TSH receptor studied in human thyroid membranes not
only activates Gs and Gq/1i but also members of the Gi and G12
families, indicating a more complex effector modulation than
a dual regulation of downstream enzymatic effectors.
MATERIALS AND METHODS
Materials. Bovine TSH was from Sigma, and [a-32P]GTP
(3000 Ci/mmol; 1 Ci = 37 GBq) was from DuPont/New
England Nuclear. TSH receptor-stimulating antibodies were
IgG preparations from four patients suffering from Grave
disease, and TSH receptor-blocking antibodies were from a
patient suffering from autoimmune hypothyroidism (diag-
nosed by standard clinical and laboratory tests). Sources of
other materials have been described (16, 17).
Membrane Preparation and Cell Culture. Human thyroid
membranes were prepared from normal glands (partly re-
moved during the resection of laryngeal cancer) or from
paranodular tissue obtained from patients undergoing thyroid-
ectomy because of solitary nodules. Dog thyroid membranes
were prepared from resected normal glands. Membranes were
prepared as described (14). FRTL-5 cells were grown as
monolayers in Coon's modified Ham's F-12 medium/5%
(vol/vol) fetal calf serum containing TSH (1 milliunit/ml),
transferrin (5 ,ug/ml), insulin (10 ,tg/ml), somatostatin (10
ng/ml), cortisone (10 nM), and the tripeptide glycyl-L-histidyl-
L-lysine acetate (10 ng/ml) in a humidified atmosphere with
5% CO2 at 37°C. Membranes were prepared by nitrogen
cavitation (6).
Photolabeling of Membrane Proteins. [a-32P]GTP azido-
anilide was synthesized and purified as described (16). Cell
membranes were incubated at 30°C in a buffer containing 0.1
mM EDTA, 10 mM MgCl2, 30 mM NaCl, 1 mM benzamidine,
and 50 mM Hepes (pH 7.4). After 5 min of preincubation with
or without receptor agonist, samples were incubated for the
indicated periods with 10 nM [a-32P]GTP azidoanilide (130
kBq per tube) in a final volume of 120 ,ul. The reaction was
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stopped by placing the samples on ice. All subsequent proce-
dures were done as described (16).
Immunoprecipitation. Immunoprecipitation was done in a
precipitating buffer containing 1% (wt/vol) Nonidet P-40, 1%
(wt/vol) deoxycholate, 0.5% (wt/vol) SDS, 150 mM NaCl, 1
mM dithiothreitol, 1 mM EDTA, 0.2 mM phenylmethylsulfo-
nyl fluoride, aprotinin at 10 ,tg/ml, and 10 mM Tris HCl (pH
7.4) (17). Fifty microliters of 10% (wt/vol) protein A-
Sepharose was added for preclearing the lysates. The subse-
quent immunoprecipitation steps were done as described (17).
SDS/PAGE, Autoradiography, Immunoblotting, and Anti-
bodies. If not stated otherwise, SDS/PAGE was performed on
separating gels containing 9% (wt/vol) acrylamide and 6 M
urea or on 13% acrylamide gels, which were run until the
prestained 30-kDa standard protein reached the gel bottom.
Photolabeled proteins were visualized by autoradiography of
dried gels with Kodak X-Omat AR-5 films. Blotting of mem-
brane proteins separated by SDS/PAGE, processing of immu-
noblots, and detection of immunoreactive proteins by a chemi-
luminescence procedure have been described (6). Antisera
were raised against peptides corresponding to specific regions
of G protein a subunits, and specificity of antisera was
controlled by testing their selectivity for a subunits expressed
in Escherichia coli. Antisera AS 8 (acommon), AS 6 (a0 common),
AS 266 (ai common), AS 190 (ail), AS 269 (ai2), AS 105 (ai3), AS
348 (as), AS 368 (aq/11/14), AS 255 (all), AS 232 (al2), AS 233
(a12), and AS 343 (a13) have been described (6, 14, 17, 18).
Antiserum AS 252 (aq) was raised against the peptide se-
quence CVAFENPYVDAIK. Antiserum AS 86 was raised
against the C-terminal 10 amino acids of ai3 (19). Antiserum
AS 371 was raised against the C-terminal sequence of ao2; it
showed crossreactivity with the three ai subtypes at a dilution
of 1:1000.
Human Thyroid Slice Incubation and cAMP Determina-
tion. Thyroid tissues were sliced at room temperature with a
Stadie-Riggs microtome (Arthur Thomas). They were first
incubated for 18 hr at 37°C under an atmosphere of 95%
02/5% CO2 (vol/vol) in 2 ml of Krebs-Ringer bicarbonate
buffer (130 mM NaCl/5 mM KCl/1.25 mM KH2PO4/20 mM
NaHCO3) supplemented with 8 mM glucose/bovine serum
albumin (0.5 g/liter)/streptomycin/penicillin (100 ,ug/ml)
containing, where indicated, pertussis toxin (200 ng/ml). Slices
were then transferred to fresh incubation medium supple-
mented with 25 ,uM rolipram and the agents to be tested. After
1 hr of incubation, the slices were dropped into boiling water
for 5 min, homogenized, and centrifuged; the supernatant was
dried in a vacuum concentrator. cAMP measurements were
performed byRIA according to the method ofBrookeretal. (20).
Reproducibility. The photolabeling experiments shown are
representative of at least three independently performed exper-
iments using different membrane preparations. cAMP measure-
ments were performed twice in triplicates, and the two-tailed
Student's t test was used to calculate significance of the data
between control conditions and pertussis toxin-treated slices.
RESULTS
To determine the G protein a-subunit expression in human
thyroid tissue, immunoblotting experiments with subtype-
specific antibodies raised against specific sequences of differ-
ent a subunits were performed (Fig. 1). An acommon antiserum,
recognizing at least the a subunits of Gil, Gi2, GO3, and Go,
reacted with several proteins in the range of 39-41.5 kDa. The
a1 common antiserum specific for the three a subunits of Gil, Gi2,
and Gi3 detected proteins with molecular masses of 40-41.5
kDa. Proteins with molecular masses of 41.5 kDa were also
recognized by antisera selective for ail and ai3, whereas the
40-kDa protein was identified by an antiserum specific for the
Q2 a subunit. An antiserum that is specific for Go a subunits
detected proteins of 39 and 40 kDa. An antiserum directed
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FIG. 1. Immunoblot analysis of G protein a subunits in membranes
of human thyroid tissue (A, B) and FRTL-5 cells (C). Thyroid
membrane proteins were separated by SDS/PAGE and blotted onto
nitrocellulose filters. For A and C, the separating gels contained 9%
acrylamide and 6 M urea; for B, SDS/PAGE was performed on 13%
acrylamide gels. Filters were cut into strips and were incubated with
the following antisera. (A) Lanes: 1, AS 8 (anti-acommon, 1:150) (21);
2, AS 266 (anti-at common, affinity purified) (8); 3, AS 190 (anti-ail,
affinity purified) (8); 4, AS 269 (anti-ai2, 1:150) (8); 5, AS 86 (anti-a3,
1:5000) (22); 6, AS 6 (anti-ca0 common, 1:100) (21); 7, AS 371 (anti-ao2,
1:5000). (B) Lanes: 1, AS 348 (anti-a,, 1:150) (21); 2, AS 252 (anti-aq,
1:150); 3, AS 368 (anti-aq/1l/14, 1:500) (23); 4, AS 255 (anti-all, 1:150)
(19); 5, AS 232 (anti-al2, 1:150) (23); 6, AS 343 (anti-aB, 1:150) (23).
(C) Lanes: 1, AS 8 (anti-acommon, 1:150); 2, AS 266 (anti-at common,
1:150); 3, AS 6 (anti-ca0 common, 1:150); 4, AS 371 (anti-ao2, 1:5000).
Bound antibodies were visualized as described. Numbers at left
indicate molecular masses (kDa) of marker proteins.
against the C terminus of ao2 selectively detected a protein at
39 kDa (AS 371 at a dilution of 1:5000). A photolabeled
40-kDa protein comigrated with another ao subunit, likely to
be aol (Figs. 2 and 3). Additional immunoblotting experiments
showed the expression of two forms of a,, a, short at 43.5 kDa
and a, long at 45 kDa, as well as of aq and all, exhibiting
molecular masses of 42 and 43 kDa, respectively. Finally, G12
and G13 a subunits were detected, migrating at 43.5 and 43 kDa,
respectively. Expression of az and a14 could not been demon-
strated in immunoblotting experiments. In membranes of
FRTL-5 cells, the acommon, ai common, and aO common antisera
immunochemically recognized the same protein pattern as in
membranes of human thyroid tissue (see Fig. 1). These data show
that the two a0 subunits immunologically detected are G proteins
endogenously expressed in the thyrocyte-derived cell line.
To investigate the possible interaction of the activated TSH
receptor with the different G proteins detected in human thyro-
cytes, membranes of thyroid glands were photolabeled with the
GTP analogue [a-32P]GTP azidoanilide in the absence or pres-
ence ofTSH at 100 milliunits/ml (Fig. 2A). Immunoprecipitation
of the 40- to 41.5-kDa a subunits of Gil, Gi2, and GO3 and the 39-
to 40-kDa a subunits of Go from solubilized membranes revealed
an increased incorporation of the GTP analogue into these G
protein a subunits in response to TSH. In addition, immunopre-
cipitation of the 43.5- and 45-kDa a subunits of G5 short and Gs long
and of the 42- and 43-kDa a subunits of Gq and G11, as well as
of the 43.5- and 43-kDa a subunits of G12 and G13, showed an
increased photolabeling in response to TSH (see Fig. 2A).
Subtype-specific immunoprecipitation for ail (AS 190), ai2 (AS
269), and aj3 (AS 105) revealed an increased photolabeling after
TSH receptor activation for the three G1 subtypes (data not
shown). To test whether this broad G protein activation via the
stimulated TSH receptor could be due to an artifact of our
membrane preparation, we tried to find a receptor selectively
activating G proteins of only one family in the same system. As
ATP and bradykinin induce inositol trisphosphate formation in
Cell Biology: Laugwitz et al.
118 Cell Biology: Laugwitz et al.
A
TSH -+ + -+ +
94 ,
67 '
- + -+ + ,++ + +
43
30
I L j . .,IL. , L-
ic P OCxqP ' q12 PPQ13 p
B
carbachol - + + - + +
94 -
67 ,
43 >
30 *
+
:8:x_ ~ ~~~1
I.*
' I L- L--j L..----
(XicPcoc p cxs Paq/1 P
X++ + +
L _j
c12 Pcq,P
FIG. 2. Immunoprecipitation of thyroid membrane G proteins
photolabeled in the presence of TSH and carbachol. (A) Human
membranes (150 ,tg/tube) were photolabeled in the absence (-) or
presence of TSH at 100 milliunits/ml (+). (B) Dog membranes were
photolabeled in the absence (-) or presence (+) of 100 ,uM carbachol
with [a-32P]GTP azidoanilide. Thereafter, membranes were solubi-
lized and incubated with the indicated antisera [aic, ac common anti-
serum (AS 266); aoc, a0 common antiserum (AS 6); as, a, antiserum (AS
348); aq/1i antiserum (AS 368); a12, a12 antiserum (AS 233); a13, a13
antiserum (AS 343)]. Control samples (P) were incubated with the
antiserum preincubated in the presence of the peptide against which
it was generated. Peptides were applied at 5 ,ug/ml (aic and aoc
antisera) or 10 jig/ml (as, aq/11, a12, and a13 antisera). Precipitated
proteins were subjected to SDS/PAGE; autoradiograms of SDS gels
are shown with molecular masses (kDa) of marker proteins at left.
human thyrocytes (24), we tried to compare the effects of these
agonists as adequate controls. Unfortunately, neither one repro-
ducibly stimulated [a-32P]GTP azidoanilide binding to a subunits
of Gq and G1I in human thyroid membranes. Because of the
weakness of these effects and because of the scarcity of the human
material, we photolabeled dog thyroid membranes with and
without 100 ,uM carbachol (Fig. 2B). Muscarinic receptor acti-
vation showed an increased incorporation of the GTP analogue
selectively into 42-kDa and 43-kDa a. subunits of Gq and GI1,
which is in accordance with reported phospholipase C stimulation
by carbachol (25). Carbachol was without any stimulatory effect
on G protein a subunits of the Gi, Gs, and G12 families (see Fig.
2B). Thus, the antibodies directed against a subunits of G,, Gq,
G1, and G12 family members specifically precipitated photola-
beled proteins with molecular masses corresponding to those
found in immunoblotting experiments, and the radioactivity
incorporated into all immunoprecipitated a subunits was in-
creased in response to TSH, suggesting that the activated TSH
receptor coupled to two forms of Gs and Go, to Gil, Gi2, Gi3, Gq,
GI , as well as to G12 and G13. Fig. 3 shows the effect of TSH at
increased concentrations on binding of the photoreactive GTP
analogue to G protein a subunits immunoprecipitated with
the a1 common, ao common, a12, a13, as, and aq/11 antisera.
Maximally effective concentrations of TSH led to a stimulation
of basal [a-32P]GTP azidoanilide incorporation into ai and ao
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FIG. 3. Effect ofTSH at increased concentrations on incorporation
of [a-32P]GTP azidoanilide into different G proteins. (Right) Mem-
branes (150 jig) were incubated with or without increased TSH
concentrations, and photolabeled a subunits were immunoprecipi-
tated with the indicated antisera as described. Immunoprecipitates
were separated by SDS/PAGE, and incorporation of [a-32P]GTP
azidoanilide into ac (AS 266), a0, (AS 6), a12 (AS 233), a13 (AS 343),
as (AS 348), aq/11 (AS 368) subunits was quantified by laser densi-
tometry of autoradiograms from dried gels. (Left) The stimulation of
photolabeling of ai (v), a0 (0), a12 (El), a13 (-),qas (short/long) (0), and
aq/ 1 (m) is shown as a percentage of maximal stimulation; mean values
of five independent experiments are shown.
subtypes by 280% and 192%, into a12 and a13 by 123% and 95%,
and into as and aq/11 by 320% and 183%, respectively. The EC50
values of TSH-induced photolabeling of G protein a subunits
were in the range of 5-50 milliunits/ml.
To test whether the effect of TSH on photolabeling of
different G protein a subunits was receptor-mediated, TSH
receptor-blocking (TB-Ab) as well as TSH receptor-
stimulating (TS-Ab) antibodies were applied (Fig. 4). Whereas
incubation of membranes with receptor-blocking antibodies
completely abolished the effect of TSH on photolabeling of
immunoprecipitated ai, ao, as, aq/11, and a12, receptor-
stimulating antibodies increased the incorporation of
[a-32P]GTP azidoanilide into these a subunits, thus mimicking
the effect of TSH. A control serum from healthy volunteers
failed to stimulate photolabeling of G protein a subunits.
Moreover, TSH at 100 milliunits/ml did not affect photola-
beling of G protein a subunits in membranes of other tissues-
e.g., liver and brain, which do not express TSH receptors (data
not shown). These data show that TSH-induced photolabeling
of different G protein a subunits in thyroid membranes
occurred by a receptor-mediated mechanism and is neither
unspecific nor due to a direct TSH effect on G proteins.
To further elucidate the coupling of the TSH receptor to Gi,
we determined intracellular cAMP concentrations after TSH
or forskolin stimulation in human thyroid slices pretreated
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FIG. 4. Effect of receptor-binding antibodies on
photolabeling of G protein a subunits. Thyroid
membranes were photolabeled with [a-32P]GTP
azidoanilide in the absence (control) or presence of
TSH alone (TSH), TSH and a TSH receptor-
blocking antiserum (T+TB-Ab), a TSH receptor-
stimulating antibody (TS-Ab), or a control serum
from healthy volunteers (nS). After solubilization,
membrane proteins were immunoprecipitated with
the antibodies indicated at top [ai,, aiC antiserum (AS
266); aoc, aO common antiserum (AS 6); as, as anti-
serum (AS 348); aq/11, aq/11 antiserum (AS 368); and
a12, a12 antiserum (AS 233)]. Autoradiogratns of
dried gels are shown. TSH and the antibodies were
applied at the following concentrations: TSH, 1
milliunit/ml (precipitation of ac and ao) or 10 mil-
liunit/ml (precipitation of as, aq/11, and a12); TB-Ab,
2 mg/ml (precipitation of ai and ao) or 3 mg/ml
(precipitation of as, aq/11, and a12); TS-Ab, 2 mg/ml;
normal human control serum, 2 mg/ml.
with or without pertussis toxin (Table 1). In pertussis toxin-
pretreated slices, the TSH-induced increase in cAMP accu-
mulation was significantly higher compared with control slices;
on average, a 32% larger increase in the cAMP concentration
was seen at various TSH concentrations. In contrast, forskolin-
dependent cAMP accumulation was unaffected by the pertus-
sis toxin pretreatment. These experiments strengthen the
photolabeling results and demonstrate coupling of the human
TSH receptor to Gs and Gi in intact cells.
DISCUSSION
In the present study, we identified the G proteins activated by
bovine TSH via the human TSH receptor in membranes of
thyroid glands. We showed that the activated TSH receptor
coupled not only to Gs and Gq/1i but also to several subtypes
of G1 and Go, as well as to GI2 and G13. No pronounced
difference in the EC50 values ofTSH to activate G proteins was
observed (Fig. 3), suggesting that the activated human TSH
receptor coupled with similar potencies to different G pro-
teins. Because this study was done with thyroid membranes
under in situ conditions that presumably maintain the physi-
ological membrane organization, an artificial receptor-G pro-
tein interaction appears unlikely; the method has been dem-
onstrated to reliably detect specific receptor G protein inter-
actions in a variety of systems (6, 10, 21, 23). We observed
selective activation of Gq and G11 in response to carbachol by
the same method in dog thyroid membranes prepared in the
same way as the human membranes; although this system is not
quite an adequate control system, the finding suggests that our
results obtained for the human TSH receptor are not an
artifact of our membrane preparations (Fig. 2B).
Our results suggest that the activated human TSH receptor
studied in thyroid membranes can couple to at least 10
different G proteins-i.e., Gs short, Gs long, Gq, G1, Gjj, Gi2, Gi3,
Go, G12, and G13. Such a high level of unspecificity or pro-
miscuity in receptor-G protein interaction is without prece-
dent so far, and the question arises whether this effect is
mediated by a single receptor or by different TSH receptors.
Alternative splicing of the receptor mRNA has been shown to
result in different isoforms-for example, the pituitary adeny-
lyl cyclase-activating peptide type I receptor. The resulting
isoforms of this receptor couple to different G proteins (22).
However, no subtypes of the TSH receptor have been de-
scribed, and the carboxyl-terminal portion of the receptor
including the seven transmembrane segments and the cyto-
plasmic surface is encoded by one single exon (26). Moreover,
receptot-stimulating and receptor-blocking antibodies af-
fected the photolabeling of all G protein a subunits activated
by TSH (see Fig. 4). Therefore, it is most likely that a single
species of TSH receptors mediated the described effects.
Despite these supporting data with antibodies against human
TSH receptors, it needs to be seen whether a similar receptor
G protein coupling pattern is observed in cotransfection or
Table 1. Influence of pertussis toxin on TSH-stimulated cAMP accumulation in human
thyroid slices
pmol of cAMP/100 mg of protein
TSH
Exp. PTX Control 0.05 mU/ml 0.1 mU/ml 1 mU/ml Forskolin
a 15.2 3.9 62 ± 14.4 145 ± 34 630 21 1131 ± 158
+ 15.1 + 2.5 79 + 6.4 184 ± 4.9 900 + 112 1122 ± 265
b 13.7 1.1 35 + 6.1 103 ± 11.3 724 + 34 1009 ± 57
+ 13.5 + 2.8 43 ± 3.7 124 ± 7.3 901 ± 108 1105 ± 8.3
c - 21 ±3.9 150 ± 21.7 508 ± 54.3 724 ± 58.9
+ 22.5 + 4 235 ± 38.5 610 ± 29 774 + 17.4
d - 24 +4.2 29 + 7.8 245 ± 47 1118 124
+ 22.3 ±4.8 35.2 ± 7.7 370 + 21 1100 + 254
Human thyroid slices were pretreated for 18 hr with pertussis toxin (PTX) at 200 ng/ml. Thereafter,
thyroid cells were incubated with TSH at the indicated concentrations and 10 ,uM forskolin in a buffer
containing 25 ,tM rolipram for 1 hr. Cells were disrupted, and cAMP accumulation was determined as
described. Results shown are means (± SEMs) of triplicates. Results were confirmed in four independent
experiments (a-d). The increase in TSH-stimulated intracellular cAMP concentrations between the
pertussis toxin-pretreated cells and the control cells was significant with P < 0.05 for TSH at 0.05 and
0.1 milliunit/ml (mU) and with P < 0.0025 for TSH at 1 milliunit/ml.
aic pOC
a ----.
94-
67
43 w.
30'-
Cell Biology: Laugwitz et al.
ddbwdk&.Aw&l.
..
AKL..
..:: ..I!!.:-
.1'Illlpw
120 Cell Biology: Laugwitz et al.
reconstitution systems. That a single, although artificial, re-
ceptor is principally able to activate a wide variety of G
proteins has recently been shown by constructing a chimeric
muscarinic M1/M2 receptor in which the third intracellular
loop or its N-terminal sequence was replaced by the corre-
sponding part of the /3 adrenergic receptor. These chimeric
receptors were able to couple to Gi, G,, Gz, Gq, and Gs with
very similar potencies (27).
Multiple evidence shows that G,-mediated signal transduc-
tion resulting in an elevated intracellular cAMP concentration
is the predominant signaling pathway induced by TSH in human
thyroid (13). Therefore, coupling of the activated TSH receptor
to Gi subtypes (see Figs. 2-4) appears to be surprising because
activation of a Gi-dependent pathway may lead to a decrease in
adenylyl cyclase activity. The increase in TSH-stimulated cAMP
accumulation in human thyrocytes after pertussis toxin treat-
ment, which leads to uncoupling of Gi family members from the
receptor, clearly underlines dual activation ofG proteins of the Gs
and Gi families via the human TSH receptor (Table 1). When
TSH-stimulated adenylyl cyclase activity is measured, Gi activa-
tion is functionally masked by the dominant Gs-mediated stim-
ulatory effect; a similar phenomenon was recently described for
the parathyroid receptor (28).
Coupling of the activated TSH receptor to subtypes of the
pertussis toxin-sensitive G proteins Gi and Go, which usually
represent the major portion of cellular heterotrimeric G
proteins, may be functionally relevant by the release of By-
complexes. /3y-heterodimers not only regulate the activity of
different enzymes-e.g., adenylyl cyclase and phospholipase C
/3 isoforms (29, 30) or phosphatidylinositol 3-kinase (31)-but
also have recently been implicated in the regulation of the ras
mitogen-activated protein kinase/extracellularly regulated ki-
nase kinase (MEK)/mitogen-activated kinase (MAP) kinase
pathway (32). The mitogenic response of human thyroid epithe-
lial cells to serum factors has been reported to be reduced by
pretreatment of cells with pertussis toxin (33), indicating that Gi
(or Go) can mediate mitogenic effects in human thyroid cells. A
TSH-induced pertussis toxin-insensitive and cAMP-independent
MAP kinase activation has been described in primary cultured
human thyroid follicles (34).
In neuronal and neuroendocrine tissues, inhibition of volt-
age-gated Ca2+ channels is mediated by Go (35). Up to now,
expression of Ca2+ channels has not been demonstrated in
human thyroid tissue either by functional or by protein or
mRNA demonstration. Despite this fact, TSH-stimulated ac-
tivation of Go proteins may play a functional role in cellular
secretion processes of thyrocytes.
Knowledge of the physiological function of G12 and G13 is
still sparse. Both G proteins have oncogenic potential in mouse
NIH 3T3 fibroblasts and are predicted to be involved in
processes of differentiation and organogenesis (36, 37). a
subunits of G13 and G12 showed the ability to stimulate
Na+/H+ exchangers (38). Our data suggest that the TSH-
induced G12 and G13 activation may elicit cellular processes
related to either growth or differentiation of thyrocytes.
Although the functional implications of the TSH-induced
stimulation of multiple signaling pathways is not clear, the fact
that a naturally occurring receptor can activate members of all
known G protein families in thyroid membranes is interesting.
This finding is in conflict with the previous concept of selective
receptor-G protein interaction and points to a highly complex
multifunctional signaling by the human TSH receptor.
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